Adaptive Biotechnologies files for $230M initial public offering
The Seattle-based biotech company spun out of the Fred Hutchinson Cancer Research Center in 2009 and has independently raised more than $400 million in funding.
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Ashley Stewart Source Type: news
More News: Biotechnology | Cancer | Cancer & Oncology | Funding | Health Management | Pharmaceuticals